“This workflow brings next-generation single-cell multiomics within reach of every lab,” said Suresh Pisharody, CEO of BioSkryb Genomics. “By reducing the need for complex cell sorting methods like ...

Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced a collaboration with Dana-Farber ...

The partners are launching ImmuneScape, a multiomics program using spatial and single-cell sequencing to study immune drivers ...

In this discussion in GEN’s “The State of Multiomics and NGS” virtual summit, originally broadcast on April 23, 2025, Jonah Cool, PhD, Science Program Officer at CZI and Sarah Teichmann, PhD, Research ...

Researchers from more than 50 international institutions have launched Open Problems, a collaborative open-source platform to benchmark, improve, and run competitions for computational methods in ...

HOLON, ISRAEL, Sept. 8, 2025 /PRNewswire/ -- Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in predictive computational target discovery, powered ...

Single-cell genomics and gene expression analysis have redefined our understanding of cellular complexity by enabling the dissection of gene activity at an individual cell level. This field leverages ...

BioSkryb Genomics, a pioneer in single-cell and ultra–low-input multiomic solutions, together with Eremid ® Genomic Services, a specialty high-complexity genomics contract research organization and ...

Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced a collaboration with Brigham & Women's Hospital, a world-class academic medical center, to analyze peripheral ...

BioSkryb Genomics and Tecan Group (SIX Swiss Exchange: TECN), today introduced a high-throughput single-cell workflow, combining BioSkryb's 384-well format of the ResolveOME(TM) Whole Genome and ...